Biogen Inc. logo

Biogen Inc. (BIIB)

Market Closed
15 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS)
$
235. 35
+2.52
+1.0823%
$
33.35B Market Cap
24.69 P/E Ratio
- Div Yield
1.57M Volume
14.99 Eps
$ 232.83
Previous Close
Add Transaction
Day Range
235.22 240.99
Year Range
138 240.99
Want to track BIIB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Biogen Inc. (BIIB) Statistics

Valuation metrics

Market Cap 33.35B
Enterprise value 40.42B
Trailing P/E (ttm) 39.74
Forward P/E 11.63
PEG ratio -0.87
Price/Sales (ttm) 3.35
Price/Book (mrq) 1.77
Enterprise Value/Revenue 4.06
Enterprise Value/EBITDA 20.67

Overview

Shares outstanding 147.6M
Float 147.18M
Shares short 4.48M
% Held by insiders 0%
% Held by institutions 0.96%
Average volume (10 days) 815K
Average volume (90 days) 1.1M

Price summary

52-Week low 138
52-Week high 240.99
Beta 0.2
50-Day moving average 219.75
200-Day moving average 194.57

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 1 Feb 2017
Ex-Dividend Date 2 Feb 2017
Last split factor 3:1
Last split Date 18 Jan 2001

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin 0.08%
Operating margin 0.13%

Operational effectiveness

Return on assets 0.03%
Return on equity 0.05%

Income Statement

Revenue (ttm) 9.94B
Revenue per share (ttm) 67.35
Quarterly revenue growth (yoy) 0.02%
Gross profit (ttm) 7.82B
EBITDA 3.27B
Net income to common (ttm) 1.37B
Diluted EPS (ttm) 5.65
Quarterly earnings growth (yoy) 0.33%

Balance Sheet

Total cash (mrq) 4.28B
Total cash per share (mrq) 8.7
Total debt (mrq) 6.56B
Total Debt/Equity (mrq) 0.44
Current ratio (mrq) 1.87%
Book value per share (mrq) 127.61

Cash Flow

Cash flow statement 2.59B
Levered free cash flow (LFCF) 1.92B